Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation

OnabotulinumtoxinA is being increasingly used in the management of chronic migraine (CM). Treatment with onabotulinumtoxinA poses challenges compared with traditional therapy with orally administered preventatives. The European Headache Federation identified an expert group that was asked to develop...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Headache Pain
Autors principals: Bendtsen, Lars, Sacco, Simona, Ashina, Messoud, Mitsikostas, Dimos, Ahmed, Fayyaz, Pozo-Rosich, Patricia, Martelletti, Paolo
Format: Artigo
Idioma:Inglês
Publicat: Springer Milan 2018
Matèries:
Consensus Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6755553/
https://ncbi.nlm.nih.gov/pubmed/30259200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-018-0921-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars